Practical method for radioactivity distribution analysis in small-animal PET cancer studies

Applied Radiation and Isotopes

Volumn 66, Issue 12, 2008, Pages 1861-1869

  Slavine, Nikolai V ^a   Antich, Peter P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

3D reconstruction; Calibrated source; PET imaging; Radioactivity analysis; Small animal cancer studies

Indexed keywords

BLIND SOURCE SEPARATION; DIAGNOSTIC RADIOGRAPHY; IMAGE ENHANCEMENT; ITERATIVE METHODS; MAXIMUM LIKELIHOOD ESTIMATION; MEDICAL IMAGING; PATHOLOGY; POSITRON ANNIHILATION SPECTROSCOPY; RADIATION; RADIOACTIVITY; RADIOISOTOPES; SEMICONDUCTOR DEVICE MODELS; SENSITIVITY ANALYSIS; TOMOGRAPHY; TUMORS;

3D RECONSTRUCTION; CALIBRATED SOURCE; PET IMAGING; RADIOACTIVITY ANALYSIS; SMALL-ANIMAL CANCER STUDIES;

POSITRON EMISSION TOMOGRAPHY;

RADIOISOTOPE;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; DOSIMETRY; HUMAN; HUMAN CELL; IMAGE RECONSTRUCTION; MALE; MAXIMUM LIKELIHOOD METHOD; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PHANTOM; PHOTON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RADIOACTIVITY; TUMOR GROWTH; TUMOR XENOGRAFT;

ALGORITHMS; ANIMALS; BONE NEOPLASMS; FLUORODEOXYGLUCOSE F18; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; WHOLE-BODY COUNTING;

EID: 53549110500     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2008.06.008     Document Type: Article

References (62)

1. Antich P.P., Constantinescu A., et al. FDG imaging of lung metastases in Copenhagen rats on a small-animal pet system with positron-encoding fiber optic detectors. J. Nucl. Med. 43 5 (2002) 216
2. Antich P.P., Parkey R., et al. Application of expectation maximization algorithms for image resolution improvement in a small-animal PET system. IEEE Trans. Nucl. Sci. 53 3 (2005) 684-690
3. 14C]-triamcinolone acetonide following oral administration. J. Clin. Pharmacol. 40 (2000) 770-780
4. Barrett H.H., and Myers K.J. Foundations of Image Science (2004), Wiley, Noboken, New Jersey
5. Beumer J.H., Rademaker-Lakhai J.M., et al. Trabectedin (Yondelis™, formerly ET-743), a mass balance study in patients with advanced cancer. Inv. New Drags 23 5 (2005) 429-436
6. Boellaard R., Nanda C., et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J. Nucl. Med. 45 9 (2004) 1519-1527
7. Clack R., Townsend D., and Jevons A. Increased sensitivity and filed of view for a rotating Positron Camer. Phys. Med. Biol. 29 11 (1984) 1421-1431
8. 11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate. J. Nucl. Med. 44 3 (2002) 341-346
9. Di Chiro G., and Brooks R. RPET quantitation: blessing and curse. J Nucl. Med. 29 (1988) 1603-1604
10. Di Domenico G., Zavattini G., et al. YAP-(S) small animal scanner: quantitative results. IEEE Trans. Nucl. Sci. 50 5 (2003) 1351-1356
11. Dikmen Z.G., Gellert G., Dogan P., et al. A new diagnostic system in cancer research: bioluminescent imaging. Turk. J. Med. Sci. 35 (2005) 65-70
12. Evilevich V., Eilber F., et al. Influence of ROI definition on the results of FDG-PET studies in patients with sarcomas. J. Nucl. Med. 48 (2007) 145P
13. Foss C.A., Mease R.C., et al. Radio labeled small-molecule ligands for prostate specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin. Cancer Res. 11 11 (2005) 4022-4028
14. Gao X., Porter A.T., Grignon D.J., et al. Diagnostic and prognostic markers for human prostate. Cancer Prostate 31 (1997) 264-681
15. Ghosh A., and Heston W.D. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J. Cell. Biochem. 91 (2004) 528-539
16. Guise T.A., Mohammad K.S., et al. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin. Cancer Res. 12 Suppl. 20 (2006) 6213s-6216s
17. Hall C.L., Bafico A., et al. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 65 17 (2005) 7554-7560
18. HBOOK, 1998. Statistical Analysis and Hostogramming, CERN Program Library Y250, CERN Geneva Switzerland, 〈www.cern.ch/cernlib〉.
19. Huang S.-C. Anatomy of SUV. J. Nucl. Med. Biol. 27 (2000) 643-646
20. Jennewein M., Constantinescu A., et al. Molecular imaging of the vascular targeting antibody Vatuximab@ in rat prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 31 (2004) 264
21. Jennewein M., Constantinescu A., Bergner O., Slavine N.V., et al. Radioactive arsenic isotopes: new tools for the imaging of tumor targeting antibodies. J. Mol. Imaging Biol. 16 150 (2004) 108-117
22. Jennewein M., Qaim S.M., et al. A new method for radiochemical separation of arsenic from irradiated germanium oxide. Appl. Radiat. Isot. 63 (2005) 343-351
23. Jennewein M., Lewis M.A., Dawen D., et al. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that bins exposed phosphatidylserine. Clin. Cancer Res. 14 (2008) 1377-1385
24. Kesner A.L., Dahlbom M., et al. Semiautomated analysis of small-animal PET data. J. Nucl. Med. 47 7 (2006) 1181-1186
25. Keyes Jr. J.W. SUV: standard uptake or silly useless value?. J. Nucl. Med. 36 10 (1996) 1836-1839
26. Kok P.J., van Eerd J.E., et al. Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection. J. Cancer Biotherapy Radiopharm. 20 3 (2005) 310-315
27. Leahy R.M., and Qi J. Statistical approaches in quantitative positron emission tomography. Stat. Comput. 10 (2000) 147-165
28. Lewis M., Arbique G., Richer E., Slavine N.V., et al. Projection and pinhole based data acquisition for small-animal SPECT using storage phosphor technology. Small-animal SPECT imaging (2005), Springer Science Media Inc., Berlin pp. 279-285 (Chapter 24)
29. Liang Z., Yoon Y., Votaw J., et al. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65 3 (2005) 967-971
30. Lin, M., Wang, Z., Kodibagkar, V.D., Slavine, N.V., et al., 2005. Multimodality imaging studies of bone metastasises in an intraosseous prostate cancer xenograft mouse model. In: Soc. Nucl. Med., 52nd Annual Meeting, Puerto-Rico, N651850.
31. Liu X., Combat C., et al. Comparison of 3D reconstruction with 3D OSEM and with FORE+OSEM for PET. IEEE Trans. Med. Imaging 20 8 (2001) 804-814
32. Mason, R., 2007. UT Southwestern In Vivo Cancer Cellular and Imaging Program, 〈http://cip.swmed.edu/ICMIC〉 Radiology, UT Southwestern at Dallas.
33. McColl, R., Faber, T., Opperman, R., et al., 1990. TR3: a simple multimodality image handling environment. In: The 10th Conference on Computer Applications to Assist Radiology, pp. 457-462.
34. National Nuclear Data Center, 2004. Brookhaven National Laboratory, 〈www.nndc.bnl.gov/nudat2〉.
35. PAW-Physics Analysis Workstation, 1995. CERN Program Library Q121 CERN Geneva Switzerland, 〈www.cern.ch/cernlib〉.
36. 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods. J. Nucl. Med. 47 3 (2006) 393-403
37. Qi J., and Leahy R.M. Iterative reconstruction techniques in emission computed tomography. Phys. Med. Biol. 51 (2006) R541-R574
38. Quarantelli M., Berkouk K., et al. Integrated software for the analysis of brain PET/SPECT studies with partial volume effect correction. J. Nucl. Med. 45 (2004) 192-201
39. Reader A.J., Erlandsson K., et al. Attenuation and scatter correction of list-mode data iterative and analytic image reconstruction algorithm for 3D PET systems. IEEE Trans. Nucl. Sci. 46 6 (1999) 2218-2226
40. Reader A.J., Ally S., Bakatselos F., et al. One-pass list-mode EM algorithm for high resolution 3d PET image reconstruction into large arrays. IEEE Trans. Nucl. Sci. 49 3 (2002) 693-699
41. Richer E., Slavine N.V., Lewis M., et al. Three dimensional light emission tomography using multiple rotating CCD cameras. J. Mol. Imaging 3 3 (2004) 229-230
42. Roodman G.D. Mechanisms of bone metastasis. N. Engl. J. Med. 350 (2004) 1655-1664
43. Roudier M.P., Vesselle H., et al. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone sintigraphy results. Clin. Exp. Metastasis 20 (2003) 171-180
44. Shepp L.A., and Vardi Y. Maximum likelihood reconstruction for emission tomography. IEEE Trans. Med. Imaging 1 (1982) 113-122
45. ©. Patent disclosure filed with University of Texas Southwestern Medical Center at Dallas in July 2007, #UTSD-1999.
46. Slavine N.V., Lewis M.A., Richer E., and Antich P.P. Iterative reconstruction method for light emitting sources based on diffusion equation. Med. Phys. 33 1 (2006) 61-68
47. Smith T. Comparison of two methods of quantitation in human studies of biodistribution and radiation dosimetry. Phys. Med. Biol. 37 (1992) 1065-1076
48. Soesbe T., Lewis M., Richer E., Slavine N.V., and Antich P.P. Development and evaluation of an EMCCD based gamma camera. IEEE Trans. Nucl. Sci. 54 5 (2007) 1516-1524
49. Takahashi Y., Otake H., et al. Variety of SUVs among different PET systems in 18F-FDG study. J. Nucl. Med. 48 (2007) 462P
50. Thie J.A., Hubner K.F., and Smith G.T. The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors. J. Nucl. Med. 41 10 (2000) 1664-1672
51. Truong M.T., Erasmus J.J., and Munden R.F. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. Am. J. Roentgenol. 183 (2004) 1127-1132
52. Tsyganov E., Anderson J., Arbique G., Constantinescu A., et al. UT SWMC small-animal positron emission imager. IEEE Trans. Nucl. Sci. 53 5 (2006) 2591-2600
53. Vandenberghe S., Asseler Y.D., et al. Iterative reconstruction algorithms in nuclear medicine. Comput. Med. Imaging Graph. 25 (2001) 105-111
54. van Weerden W.M., and Romijn J.C. Use of nude mouse xenograft models in prostate cancer research. Prostate 43 (2000) 263-271
55. 11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ specific evaluation. J. Nucl. Med. 49 3 (2008) 347-352
56. Wells K., Chiverton J., et al. Quantifying the partial volume effect in PET using Benford's low. IEEE Trans. Nucl. Sci. 54 5 (2007) 1616-1625
57. Wipke B.T., Wang Z., et al. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J. Immunol. (2004) 7694-7702
58. Wu T.T., Sikes R.A., et al. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int. J. Cancer 77 (1998) 887-894
59. 64Cu-labeled tetrametric RGD peptide. J. Nucl. Med. 46 10 (2005) 1707-1718
60. 18F-FRGD2. J. Nucl. Med. 47 1 (2006) 113-121
61. Zhong H., Weiss E., and Siebers J.V. Assessment of dose reconstruction errors in image-guided radiation therapy. Phys. Med. Biol. 53 (2008) 719-736
62. Zinchenko A., Tsyganov E., Slavine N.V., et al. Expectation maximization algorithm with resolution deconvolution for 3d image reconstruction in small-animal PET imager. J. Nucl. Med. 44 5 (2003) 165-166